Wyeth Supreme Court Case Could Have Impact On Device Suits, Lawyers Say
This article was originally published in The Gray Sheet
Executive Summary
If the Supreme Court favors "implied" federal pre-emption for FDA-approved pharmaceutical labeling in a case that will be heard by the court next month, some devices may receive additional protections too, lawyers suggest